1-Perhydro-2H-pyran-2-yl-3-[3-(3-piperidylpropanoylamino)phenyl]-1H-indazole-5-carboxamide → 3-[3-(3-Piperidylpropanoylamino)Phenyl]-1H-Indazole-5-Carboxamide

HRID 2183289Notes

Reaction equation

HRID 2183289 reaction equation
O1CCCCC1[N:7]1[C:15]2[C:10](=[CH:11][C:12]([C:16]([NH2:18])=[O:17])=[CH:13][CH:14]=2)[C:9]([C:19]2[CH:24]=[CH:23][CH:22]=[C:21]([NH:25][C:26](=[O:35])[CH2:27][CH2:28][CH:29]3[CH2:34][CH2:33][CH2:32][NH:31][CH2:30]3)[CH:20]=2)=[N:8]1>C1(C)C=CC=CC=1>[NH:31]1[CH2:32][CH2:33][CH2:34][CH:29]([CH2:28][CH2:27][C:26]([NH:25][C:21]2[CH:20]=[C:19]([C:9]3[C:10]4[C:15](=[CH:14][CH:13]=[C:12]([C:16]([NH2:18])=[O:17])[CH:11]=4)[NH:7][N:8]=3)[CH:24]=[CH:23][CH:22]=2)=[O:35])[CH2:30]1

Participants

3

Procedure

1-Perhydro-2H-pyran-2-yl-3-[3-(3-piperidylpropanoylamino)phenyl]-1H-indazole-5-carboxamide was suspended in 20 mL of toluene and HCl gas was bubbled through for 15 min. The reaction mixture became gummy and was stirred at room temperature overnight. The supernatant solution was decanted and the residue was purified by preparatory HPLC. (0.017 g, 7% yield over 2 steps): 1H NMR (DMSO d6) δ 13.48 (s, 1H), 10.38 (s, 1H), 8.62 (s, 1H), 8.1 (s, 1H), 7.94 (dd, 1H), 7.94 (dd, 1H), 7.73 (d, 1H), 7.62 (d, 1H), 7.48 (t, 1H), 7.36 (br s, 1H), 2.65 (m, 2H), 2.5 (m, 2H), 2.4 (br s, 4H), 1.52 (m, 4H), 1.40 (m, 2H); ES-MS (m/z) 392 [M+H]+.

Workup

  1. customHCl gas was bubbled through for 15 min
  2. customThe supernatant solution was decanted
  3. customthe residue was purified by preparatory HPLC

Sources & evidence

ORD record
ord-643f73dca919413b978e6045f17ba60f
Source dataset
uspto-grants-2005_05
Patent number
US06897231B2

Reaction notes

Loading…